AU3402301A - Azole compounds as therapeutic agents for fungal infections - Google Patents

Azole compounds as therapeutic agents for fungal infections Download PDF

Info

Publication number
AU3402301A
AU3402301A AU34023/01A AU3402301A AU3402301A AU 3402301 A AU3402301 A AU 3402301A AU 34023/01 A AU34023/01 A AU 34023/01A AU 3402301 A AU3402301 A AU 3402301A AU 3402301 A AU3402301 A AU 3402301A
Authority
AU
Australia
Prior art keywords
hydroxy
group
amino
compound
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU34023/01A
Other languages
English (en)
Inventor
Jasbir Singh Arora
Sudershan K. Arora
Ashok Rattan
Ashwani Kumar Verma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IN198DE2000 external-priority patent/IN191188B/en
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of AU3402301A publication Critical patent/AU3402301A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU34023/01A 2000-03-07 2001-03-01 Azole compounds as therapeutic agents for fungal infections Abandoned AU3402301A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN198/DEL/2000 2000-03-07
IN198DE2000 IN191188B (xx) 2000-03-07 2000-03-07
US09575578 2000-05-22
US09/575,578 US6670363B1 (en) 2000-03-07 2000-05-22 Azole compounds as therapeutic agents for fungal infections
PCT/IB2001/000300 WO2001066551A2 (en) 2000-03-07 2001-03-01 Azole compounds as therapeutic agents for fungal infections

Publications (1)

Publication Number Publication Date
AU3402301A true AU3402301A (en) 2001-09-17

Family

ID=26324879

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34023/01A Abandoned AU3402301A (en) 2000-03-07 2001-03-01 Azole compounds as therapeutic agents for fungal infections

Country Status (8)

Country Link
EP (1) EP1278755A2 (xx)
JP (1) JP2004501867A (xx)
AU (1) AU3402301A (xx)
CA (1) CA2402345A1 (xx)
NZ (1) NZ521241A (xx)
PL (1) PL365072A1 (xx)
RU (1) RU2002126272A (xx)
WO (1) WO2001066551A2 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002218505A1 (en) * 2000-11-30 2002-06-11 Senju Pharmaceutical Co. Ltd. Pancreatitis remedies and medicines for prevention and therapy of reflux esophagitis
US6710049B2 (en) 2000-12-26 2004-03-23 Ranbaxy Laboratories Limited Azole compounds as anti-fungal agents
DE60234812D1 (de) 2001-01-29 2010-02-04 Shionogi & Co Arzneipräparat, das als wirkstoff 5-methyl-1-phenyl-2-(1h)-pyridon enthält
HUP0303249A3 (en) 2001-02-22 2007-03-28 Sankyo Co Water-soluble triazole fungicide compounds and pharmaceutical compositions containing them
IN192526B (xx) * 2001-09-25 2004-04-24 Ranbaxy Lab
AU2002328176A1 (en) * 2002-08-26 2004-03-11 Ranbaxy Laboratories Limited Azole derivatives as antifungal agents
EP1413301A1 (fr) * 2002-10-24 2004-04-28 Bayer CropScience SA Médicaments antifongiques à base de dérivés d'arylamidine
WO2007020888A1 (ja) 2005-08-12 2007-02-22 Takeda Pharmaceutical Company Limited 脳・神経細胞保護剤および睡眠障害治療薬
EP2709609B1 (en) 2011-05-17 2017-10-04 Shionogi & Co., Ltd. Heterocyclic compounds
US9907812B2 (en) 2011-06-22 2018-03-06 Vyome Biosciences Pvt. Ltd. Conjugate-based antifungal and antibacterial prodrugs
CN102617494B (zh) * 2012-03-15 2014-10-29 南京工业大学 一种含有烯醚结构的三唑类化合物及其制备方法和用途
NZ714817A (en) 2013-06-04 2017-07-28 Vyome Biosciences Pvt Ltd Coated particles and compositions comprising same
MY188541A (en) 2014-01-29 2021-12-21 Vyome Therapeutics Ltd Besifloxacin for the treatment of resistant acne
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
AR109545A1 (es) 2016-09-29 2018-12-19 Bayer Cropscience Ag Derivados de triazol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW218017B (xx) * 1992-04-28 1993-12-21 Takeda Pharm Industry Co Ltd
CA2134417A1 (en) * 1993-12-22 1995-06-23 Katsumi Itoh Optically active azole derivatives, their production and use
US5639754A (en) * 1994-07-12 1997-06-17 Janssen Pharmaceutica N.V. Urea and thiourea derivatives of azolones
EP0957101A1 (en) * 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals

Also Published As

Publication number Publication date
CA2402345A1 (en) 2001-09-13
WO2001066551A8 (en) 2003-06-26
RU2002126272A (ru) 2004-08-10
NZ521241A (en) 2004-02-27
WO2001066551A2 (en) 2001-09-13
PL365072A1 (en) 2004-12-27
JP2004501867A (ja) 2004-01-22
EP1278755A2 (en) 2003-01-29
WO2001066551A3 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
CA2680292C (en) Intermediates useful for the preparation of n-substituted carbamoyloxyalkyl-azolium derivatives
EP0567982B1 (en) Azole compounds, their production and use
US7459561B2 (en) N-substituted carbamoyloxyalkyl-azolium derivatives
AU3402301A (en) Azole compounds as therapeutic agents for fungal infections
AU678278B2 (en) Azole compounds, their production and use
KR100572996B1 (ko) 불소화 비닐 에테르 측쇄기를 갖는 아졸계 살균제 화합물및 그의 제조방법
JPH1045750A (ja) アゾール化合物、その製造方法及び用途
JPH0649033A (ja) 光学活性アゾール化合物およびその用途
DK160091B (da) 1-heterocyclyl-2-phenyl-3-(1,2,4-triazol-1-yl)propan-2-ol-forbindelser og farmaceutisk acceptable salte deraf samt farmaceutisk praeparat indeholdende disse forbindelser eller salte
AU740324B2 (en) New triazoles as therapeutic agents for fungal infections
US6670363B1 (en) Azole compounds as therapeutic agents for fungal infections
KR100252433B1 (ko) 엔-벤질아졸륨 유도체
NZ530614A (en) Azole compounds as therapeutic agents for fungal infections
US6153616A (en) Triazoles as therapeutic agents for fungal infections
CA2405919A1 (en) 1-(h-1,2,4-triazol-1-yl)butan-2-ol derivatives
CA2433259A1 (en) Azole compounds as anti-fungals agents
JPH08104676A (ja) アゾール化合物、その製造方法及び用途

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase